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Chapter 8 
 
Salivary gland 
 
Selected salivary grand cell culture  
Salivary gland atrophy is commonly seen in patients in whom those salivary glands have 
been irradiated for oral and facial cancer treatment. In addition, aging has been reported to 
induce histological changes in the parenchyma of the salivary glands such as the 
replacement with fat or connective tissue [1]. The atrophic gland leads to dry mouth, a 
condition frequently associated with various symptoms including active dental caries, a 
burning sensation in the mouth, and difficulty with eating, swallowing or speech. Moreover, 
an increased incidence of infection such as oral candidiasis has been reported [2]. Patients 
with dry mouth have been treated with salivary substitutes and/or medications such as 
pilocarpine or cevimeline hydrochloride [3]. These treatments temporarily relieve the 
patients’ symptoms, inducing salivation from the residual tissue. However, no treatment is 
available for the purpose of regenerating the atrophic glands. 
Recently, the possibility of re-engineering atrophic or damaged salivary glands has been 
explored with the aim of developing novel clinical treatments [4]. Gene therapy for the 
salivary gland shows promise as a future treatment adjunct, since gene transfer to an 
irradiated salivary gland has been shown to increase fluid secretion in an animal model [5]. 
However, the clinical application of gene therapy to the atrophic glands requires further 
development and validation of the new vehicles for gene delivery, since currently available 
viral or nonviral vectors still require some considerations regarding safety, efficiency or the 
duration of transgene expression. Tissue engineering is a promising new approach to the 
replacement of lost or damaged tissue. Therefore, we attempted to establish a method for 
culturing normal epithelial salivary gland cells. Monolayer culture of salivary-gland cells has 
the advantage of allowing investigation of the effects of individual biochemical substances 
without the influence of other modifying factors. However, the use of monolayer culture 
techniques on cells from the normal salivary gland requires the elimination of contaminating 
fibroblasts and the maintenance of cell proliferation for prolonged periods. To avoid 
contamination by fibroblasts and other cell types, Olivar tried to select specific cell types using 
Ficoll (Pharmacia) density-gradient centrifugation, but he reported only the suspension culture 
protocols [6]. The same aims were addressed by Yang et al., using low Ca2+ concentrations in 
his medium as well as a collagen gel matrix [7]. This method exhibited fibroblast proliferation 
and allowed salivary-gland cells to exhibit a duct-like appearance. While this technique 
permitted investigation of tissue morphology, it was difficult to investigate cellular 
proliferation. To inhibit contamination by fibroblasts, and to obtain a stable monolayer of 
cultured cells in a short time, Sabatini et al. used 3T3 cells as a feeder layer for salivary-gland 
cell culture [8]. The 3T3 cells inhibited the proliferation of fibroblasts while maintaining the 
proliferative activity of adjacent epithelial cells for prolonged periods of time without 
differentiation. The same group reported the presence of two types of cell in these cultures; 
one cuboidal and in close contact with the surrounding cells, the other rounded without 
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cell-to-cell contact. So, we modified their method to selectively culture acinar cells during the 
first and second passages. The method is described in detail in the following  
 
Preparation of 3T3 cells  
The 3T3 cells were kindly provided by Dr. Howard Green (Department of Cellular and 
Molecular Physiology, Harvard Medical School, Boston, MA, U.S.A.). To suppress cell 
proliferation, they were treated with 4 µg/ml mitomycin C in DMEM for 2 hours at 37°C 
without fetal bovine serum. Cells treated in this manner promote the proliferation of 
adjacent epithelial cells but do not proliferate themselves. After incubation, the 3T3 cells 
were rinsed three times with Hank’s solution to remove the mitomycin C. 
 
Tissue preparation and salivary gland epithelial cell culture 
The submandibular glands were excised from Wistar rat and rinsed in PBS containing 100 
U/ml penicillin, 0.1 mg/ml streptomycin, and 0.25 µg/ml amphotericin B. Using curved 
scissors, the tissues were cut into cubes of at least 1 mm3. Salivary gland cells were 
dissociated by digestion with a solution of 0.1 mg/ml collagenase in PBS for 30 minutes at 
room temperature. Cells were then stirred for 30 minutes with a magnetic stirring bar, 
filtered through a 70-µm nylon mesh, and collected by centrifugation for 5 minutes at 1500 
rpm. The separated salivary gland cells were cultured in 75-cm plastic flasks, in a 
humidified atmosphere of 10% CO2 at 37°C in a 3: 1 mixture of DMEM and Ham’s F-12 
containing 5% fetal bovine serum, 5.0 µg/ml insulin, 5.0 µg/ml transferrin, 2 × 10-9 M 
tri-iodothyronine, 1×10-9 M cholera toxin, 0.4 µg/ml hydrocortisone, 0.1 µg/ml epidermal 
growth factor, 10 U/ml penicillin, 0.1 mg/ml streptomycin, and 0.25 µg/ml amphotericin B 
(Fig. 37). To confirm the origin of these cultured cells, amylase production was examined by 
electron microscopy and periodic acid Schiff staining, together with immunocytochemical 
analysis of myosin, anticytokeratin (CK-1, CK 10/13, CK-MNF116, CK-LMW, CK-HMW 
and CK-19) and amylase antibody.  
 
A 
B 
C 
 
Fig. 37. Protocol of salivary gland epithelial cell culture. A: Excise salivary glands, and cut 
into cubes of at least 1 mm3. B: Dissociation by digestion with a solution of 0.1 mg/ml 
collagenase in PBS for 30 minutes and filtered through a 70-µm nylon mesh. C: Cell culture 
(From Horie et al. 1996. Reprinted with permission). 
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The cultured cells demonstrated secretion granules containing amylase and presented features 
characteristic of acinar cells, which they retained until passage two. By using a feeder layer in 
conjunction with a newly formulated culture medium, the selectability of these cells was 
improved. Changes in proliferation of cultured salivary-gland cells in the presence of selected 
neurotransmitters were also examined, Isoproterenol enhanced cellular proliferation. 
Thus, we established a culture method for normal epithelial salivary gland cells. However, 
tissue engineering of a whole organ is still not feasible since it requires the regeneration of a 
complex ductal system, blood supply and renervation, none of which are possible with the 
current technology. Cell transplantation is also a possible treatment option to restore the 
function of lost or damaged tissue, and has been extensively studied in cases of type I diabetes 
[9-12], Parkinson’s disease [13-15], and liver dysfunction [16]. Most such studies have aimed to 
restore the function of a specific cell type or cell groups in an organ. The possibility of 
regenerating an entire organ by cell transplantation has not been demonstrated except for the 
liver, which possesses enormous regenerative capacity [17]. Recent studies have shown that 
transplanted bone marrow cells might replace tissue in many more organs than was previously 
thought possible. If this is the case, transplanted salivary gland stem cells could eventually 
restore at least part of the organ after extensive cell proliferation and differentiation. Since the 
cell therapy approach can avoid some of the technical difficulties posed by tissue engineering, 
it is worthwhile investigating its potential for the treatment of atrophic salivary glands. 
 
Cell transplantation into an atrophic salivary gland 
Next, we investigated the feasibility of a cell therapy for an atrophic salivary gland using 
cultured salivary gland cells, we established the culture method. First, we investigated the 
survival and distribution of transplanted cells in the salivary gland. Second, we 
demonstrated a possible differentiation of the transplanted cells. Third, we examined the 
possible drawbacks of cell transplantation on normal salivary glands since the cells could be 
harmful if they attach and remain within a normal tissue structure. Below is how to generate 
an atrophic salivary gland model and transplant the cultured cells into atrophic glands.  
 
Generation of atrophic submandibular gland by ductal ligation  
The atrophic submandibular gland was generated by a ductal ligation according to Tamarin 
with modifications [18, 19]. Briefly, the main ducts of the left submandibular-sublingual glands 
of male Wistar rats (each weighing about 200 g) were exposed surgically. The ducts with some 
surrounding connective tissue investments were isolated by blunt dissection under a surgical 
microscope. A specially prepared stainless steel tube and a nylon ligature were looped around 
each duct and tied. The tissues were then reapposed and the skin was sutured. The ligation 
period lasted one week for all experiments. One week after ductal ligation, atrophy of the 
acinar cells was observed. Ducts were dilated and fibrous connective tissues were prominent. 
 
Cell transplantation 
The procedure and protocol for our cultured salivary gland epithelial cell transplantation 
are summarized in figure (Fig. 38). Prior to transplantation, the cultured salivary gland 
epithelial cells were detached from culture dishes by enzymatic treatment with 0.05% 
trypsin-EDTA. The cells were then labeled with a fluorescent cell linker PKH26 at a 
concentration of 2 × 10-6 M for 5 minutes. The cell pellet was resuspended in DMEM 
containing 10% fetal bovine serum to yield a density of 50,000 cells/µl. India ink was added 
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to the cell suspension at a 1:200 dilution in order to locate the injection site. Twenty 
microlitters of the cell suspension containing 2 × 106 PKH26-labeled cultured cells was 
injected through a 25-gauge needle into the atrophic submandibular gland. When the 
injections were properly placed, India ink was visible below the capsules. In the control 
group, the same cell suspension was injected into normal submandibular glands.  
 
 
Fig. 38. Schema ofexperimental protocol. (a) Excise submandibular glands. (b) Cell culture. 
(c) Cell labeling with PKH. (d) Cell transplantation intoatrophic submandibular glands. (e) 
Cell transplantation into normal submandibular glands (From Sugito et al. 2004). 
 
The submandibular glands were excised at 2 and 4 weeks after transplantation. At least four 
animals were used at each of the above time points in both the experimental and control 
groups. The excised glands were fixed in 10% buffered formalin and embedded in OCT 
Compound on dry ice. The samples were then stored at -80°C until the time for cryosectioning.  
Two weeks after cell transplantation, the transplanted cells were detectable in both the 
experimental and control groups. The cells were clustered in the connective tissue between the 
lobules. Four weeks after transplantation, the labeled cells were detectable in the experimental 
group but not in the control group. In the atrophic glands, the scattered transplanted cells 
were observed over a broad area of the gland but localized mainly around the acini and ductal 
region. Immunostaining results showed a possible involvement of the transplanted cells in 
ductal regeneration, while neither myoepithelial nor acinar differentiations were observed 
within the four weeks since transplantation. This study demonstrated that cell transplantation 
to the salivary gland is feasible, and that the transplanted cells were selectively attracted to and 
remained in the damaged area without affecting normal tissue. 
The present study described the possibility of cell therapy for the salivary gland by use of 
cultured normal salivary epithelial cells. However, these results are very preliminary since the 
period of observation was short, and the longer-term fate of the transplanted cells is not 
known. Long-term observations as well as investigations into a suitable cell source are areas 
for future studies.  
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Tissue engineering, which aims at regenerating new tissues, as well as substituting lost organs by making use
of autogenic or allogenic cells in combination with biomaterials, is an emerging biomedical engineering field.
There are several driving forces that presently make tissue engineering very challenging and important: 1) the
limitations in biological functions of current artificial tissues and organs made from man-made materials alone,
2) the shortage of donor tissue and organs for organs transplantation, 3) recent remarkable advances in
regeneration mechanisms made by molecular biologists, as well as 4) achievements in modern biotechnology
for large-scale tissue culture and growth factor production. 
This book was edited by collecting all the achievement performed in the laboratory of oral and maxillofacial
surgery and it brings together the specific experiences of the scientific community in these experiences of our
scientific community in this field as well as the clinical experiences of the most renowned experts in the fields
from all over Nagoya University. The editors are especially proud of bringing together the leading biologists
and material scientists together with dentist, plastic surgeons, cardiovascular surgery and doctors of all
specialties from all department of the medical school of Nagoya University. Taken together, this unique
collection of world-wide expert achievement and experiences represents the current spectrum of possibilities in
tissue engineered substitution.
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